Table 1.
Clinicopathological characteristics of breast cancer patients and controls in discovery cohort: cohort #1.
| Characteristics | Tissue Samples | ||
|---|---|---|---|
| Breast Cancer Patients | Controls | ||
| Number | 103 | 26 | |
| Median age, years (range) | 59.7 (57–62) | 54.6 (47–63) | |
| Molecular subtype, n (%) | |||
| Luminal | 59 (57.3%) | n.a. | |
| TNBC | 30 (29.1%) | ||
| Her 2 | 14 (13.6%) | ||
| Grade group, n (%) | |||
| 1 | 9 (8.7%) | n.a. | |
| 2 | 36 (35%) | ||
| 3 | 46 (44.7%) | ||
| Unknown | 12 (11.6%) | ||
| Stage, n (%) | |||
| I | 12 (11.7%) | n.a. | |
| II | 63 (61.2%) | ||
| III | 13 (12.6%) | ||
| Unknown | 15 (14.6%) | ||
| Pathological T stage, n (%) | |||
| pT1 | 24 (23.3%) | n.a. | |
| pT2 | 57 (55.3%) | ||
| pT3 | 6 (5.8%) | ||
| pT4 | 1 (1%) | ||
| Unknown | 15 (14.6%) | ||
| Regional lymph node metastasis, n (%) | |||
| No | 39 (37.9%) | n.a. | |
| Yes | 50 (48.5%) | ||
| Unknown | 14 (13.6) | ||
| Distant metastasis, n (%) | |||
| No | 89 (86.4%) | n.a. | |
| Yes | 0 (0%) | ||
| Unknown | 14 (13.6%) | ||
| TNBC, triple-negative breast cancer; n.a., not applicable | |||